GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MaxCyte Inc (LSE:MXCT) » Definitions » Float Percentage Of Total Shares Outstanding

MaxCyte (LSE:MXCT) Float Percentage Of Total Shares Outstanding : 99.15% (As of May. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is MaxCyte Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, MaxCyte's float shares is 103.65 Mil. MaxCyte's total shares outstanding is 104.54 Mil. MaxCyte's float percentage of total shares outstanding is 99.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, MaxCyte's Insider Ownership is 1.66%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, MaxCyte's Institutional Ownership is 44.92%.

MaxCyte Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

MaxCyte's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=103.65/104.54
=99.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MaxCyte (LSE:MXCT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MaxCyte Inc (LSE:MXCT) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
LSE:NIOX LSE:EKF LSE:CREO LSE:BELL LSE:IUG LSE:IHC LSE:POLX LSE:SUN LSE:MHC LSE:DEMG ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
MXCT:USA MYE0:Germany
Address
9713 Key West Avenue, Suite 400, Rockville, MD, USA, 20850
Website
https://www.maxcyte.com
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.